Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
Clocks to go forward one hour in Europe as summer time starts- Remote Headphones: Improve Your Sound Insight
- Most loved Caf\u00e9 Chain: Where Do You Get Your Caffeine Fix
- One spent $20 on candy. Another paid $700 for a custom costume. Here's how Halloween costs stacked up this year.
- How the Iran war may affect your money and bills
- The 10 Most Persuasive Forerunners in Innovation
- Israel reports first missile fire from Yemen since start of Iran war
- France, Germany, Italy summon Iranian envoys over 'unbearable, inhumane' regime crackdown
- Mossad unveils network of Hamas terror infrastructure across Europe
